InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Fox-Colis Aaron. Director active across 1 company, notably Fresh Tracks Therapeutics, Inc.. Cumulatively, 1 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €28. History available since 4 December 2023. The latest transaction was disclosed on 4 December 2023 (Cession). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration